Insider Selling: Heartflow (NASDAQ:HTFL) CEO Sells 32,676 Shares of Stock

Posted by Amy Steele on Aug 20th, 2026

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) CEO John C.M. Farquhar sold 32,676 shares of the firm’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $45.00, for a total value of $1,470,420.00. Following the transaction, the chief executive officer owned 388,044 shares in the company, valued at approximately $17,461,980. This trade represents a 7.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total transaction of $607,773.60.
On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.31, for a total transaction of $638,730.22.
On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $27.75, for a total transaction of $626,095.50.
On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00.
On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total value of $643,017.00.

Heartflow Stock Up 2.8%

Shares of HTFL traded up $1.27 during midday trading on Thursday, hitting $46.80. The company’s stock had a trading volume of 1,989,666 shares, compared to its average volume of 1,522,363. Heartflow, Inc. has a one year low of $20.13 and a one year high of $47.95. The stock has a market capitalization of $4.07 billion and a price-to-earnings ratio of -25.57. The company’s fifty day simple moving average is $30.00 and its two-hundred day simple moving average is $28.05.

Heartflow (NASDAQ:HTFL – Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business had revenue of $64.08 million for the quarter. The firm’s revenue was up 47.7% compared to the same quarter last year. On average, research analysts predict that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Hedge Funds Weigh In On Heartflow

Large investors have recently modified their holdings of the business. XXEC Inc. acquired a new stake in Heartflow in the second quarter valued at $2,524,764,000. BlackRock Inc. acquired a new position in Heartflow during the 2nd quarter worth about $152,502,000. Wellington Management Group LLP bought a new stake in shares of Heartflow in the 3rd quarter valued at about $164,263,000. Bamco Inc. NY acquired a new stake in shares of Heartflow in the second quarter valued at about $94,625,000. Finally, Jupiter Topco LLC bought a new position in shares of Heartflow during the second quarter worth about $70,983,000.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on HTFL shares. Stifel Nicolaus boosted their target price on shares of Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. William Blair started coverage on Heartflow in a research note on Monday, May 4th. They issued an “outperform” rating for the company. Benchmark reissued a “buy” rating on shares of Heartflow in a report on Friday, August 14th. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, August 7th. Finally, Wells Fargo & Company increased their target price on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $43.43.

Check Out Our Latest Report on Heartflow

Heartflow Company Profile

(Get Free Report)

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.